高级搜索
黄桂芹, 付宇, 缪明星, 颜天华. 铁死亡介导的抗肿瘤免疫治疗研究进展[J]. 肿瘤防治研究, 2023, 50(7): 700-704. DOI: 10.3971/j.issn.1000-8578.2023.22.1321
引用本文: 黄桂芹, 付宇, 缪明星, 颜天华. 铁死亡介导的抗肿瘤免疫治疗研究进展[J]. 肿瘤防治研究, 2023, 50(7): 700-704. DOI: 10.3971/j.issn.1000-8578.2023.22.1321
HUANG Guiqin, FU Yu, MIAO Mingxing, YAN Tianhua. Research Progress on Ferroptosis-mediated Antitumor Immunotherapy[J]. Cancer Research on Prevention and Treatment, 2023, 50(7): 700-704. DOI: 10.3971/j.issn.1000-8578.2023.22.1321
Citation: HUANG Guiqin, FU Yu, MIAO Mingxing, YAN Tianhua. Research Progress on Ferroptosis-mediated Antitumor Immunotherapy[J]. Cancer Research on Prevention and Treatment, 2023, 50(7): 700-704. DOI: 10.3971/j.issn.1000-8578.2023.22.1321

铁死亡介导的抗肿瘤免疫治疗研究进展

Research Progress on Ferroptosis-mediated Antitumor Immunotherapy

  • 摘要: 铁死亡是一种铁依赖性脂质过氧化驱动的程序性细胞死亡方式,与衰老、免疫以及癌症等广泛的生物学背景密切相关。肿瘤耐药性的产生,特别是对凋亡的抗性,迫切需要寻求一种新的抗肿瘤治疗方案。近年来,铁死亡在抗肿瘤作用中的研究取得重大进展,特别是与免疫细胞的相互作用。基于铁死亡途径研究免疫治疗已成为抗肿瘤研究的新方向。该文将围绕铁死亡与免疫细胞之间的作用,以及铁死亡介导的抗肿瘤免疫治疗展开综述,以期为铁死亡介导的抗肿瘤免疫治疗提供新的思路。

     

    Abstract: Ferroptosis is a form of programmed cell death driven by iron-dependent lipid peroxidation and is closely associated with a wide range of biological processes, such as aging, immunity, and cancer. Tumor multidrug resistance, especially resistance to apoptosis, has prompted the urgent search for a new antitumor treatment option. Remarkable progress has been made in the study of the role of ferroptosis in antitumor, especially the interaction with immune cells. Studying immunotherapy based on ferroptosis pathways has become a new direction in antitumor research. In this work, we review the role of ferroptosis in immune cells and antitumor immunotherapy to provide new ideas for ferroptosis-mediated antitumor immunotherapy.

     

/

返回文章
返回